The Foundation of the Carlo Besta Neurological Institute, is, under Italian Civil Law, a “Foundation of Participation,” in which representatives within the Board of Governors play a prominent role. Members of the Board of Governors include representatives of the Italian Ministry of Health, the Region of Lombardy, and the Municipality of Milan − all of which are Founders of the Besta Foundation.
The organs of the Besta Foundation are the President, the Board of Governors, the General Manager, the Scientific Director, and the Board of Auditors.
The Carlo Besta Neurological Institute, first established in 1918, was designated by the Italian government as an Institute of Research and Treatment (IRCCS) in 1981. On July 15, 2006 the Institute transformed into the Foundation of the Carlo Besta Neurological Institute, IRCCS, in accordance with Italian Legislative Decree No. 288 of 2003. The activity of the Foundation is governed by its Statute approved by Italian Ministry of Health, April 28, 2006.
The Foundation of the Carlo Besta Neurological Institute, IRCCS, is a regional and national centre of excellence for the treatment of neurological diseases, and also undertakes research aimed to improve the diagnosis and treatment of these diseases. The Foundation treats oncological, degenerative and rare neurological diseases affecting both children and adults, and is highly active in the field of neurosurgery. It is a regional and national referral centre for several specific neurological conditions.
The fundamental aims of the Foundation are to provide high quality, ethical and efficient care and treatment to its patients, making use of the results of it own research and that of others, always putting the interests of patient first. In fulfilment of these aims, the Foundation provides care and treatment to patients, carries out clinical and basic research to improve treatment and diagnosis (translational research), provides professional training and educational programmes (including those for pre and postgraduate university students) and develops new managerial techniques to improve health care provision and research efficiency.
Contact
Via Celoria 11, 20133 Milano (Italy)
Tel. +39 02.23941 – Fax +39 02.70638217
Presidente
Carlo Borsani
tel. 02.26684954
fax 02.2394.2980
Direttore Generale
Giuseppe De Leo
tel. 02.2394.2310
fax 02.2394.2531
e-mail dirgen@istituto-besta.it
Direttore Scientifico
Ferdinando Cornelio
tel. 02.2394.2335
fax 02.2363973
e-mail dirsci@istituto-besta.it
Alberto Gugliemo, President of the Carlo Besta Institute in Milan, shares the changing perception of neurological diseases and neurological science in Italy, the nature of the institute’s collaboration with the…
You have worked in other countries such as the UK and the US with very large and significant pharmaceutical industries. What would you say is particular about the Italian pharmaceutical…
Since 1982, CNR has been the Italian public body which most contributed to the creation of inventions and innovations. What have been the main strategies behind such a success in…
Over more than 25 years, PAREXEL has expanded its global footprint through a combination of organic growth, alliances, and acquisitions. What was the rationale behind entering Italy in 1995 and…
“The ball is in the hands of the government,” according to Giorgio Foresti, general manager of Ratiopharm. “Once aware of the opportunities created by generics, politicians will have to make…
The pharmaceutical industry arose from science – and so did Italy’s knowledge based economy. Building on a reputation for innovation carved in the 15th century, when Leonardo Da Vinci, Michelangelo,…
Petrone group was created in 1965, based on your parents’ Carmine and Fernanda’s entrepreneurial spirit. They survived through times of challenges for Italian groups and maintained their independence. In your…
Scharper’s history in the Italian market begins in 1958, but the company as we see it today was really created in the mid nineties, when you founded La Farmochimica Italiana…
See our Cookie Privacy Policy Here
